Feedback / Questions
NNI-362 - NeuroNascent
https://www.globenewswire.com/news-release/2023/08/22/2729259/0/en/Neuronascent-Announces-NIA-Grant-Award-for-NNI-362-to-Reach-Phase-2-Clinical-Trials-for-Mild-to-Moderate-Alzheimer-s-Disease.html
Aug 22, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next